Lisa M Jarvis

Pharma Columnist

AS SEEN ON

Preston's Summary

Lisa M Jarvis is a Pharma columnist for Bloomberg News. With a focus on drug discovery, rare diseases, R&D, biotech, and Covid-19, Lisa provides insights and opinions on the intersection of science and business in the pharmaceutical industry. Her articles cover a range of topics, from breakthroughs in targeted cancer drugs to the challenges of vaccine rollouts and the impact of court decisions on healthcare access.

Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston

Geo Focus

United States (National)

Coverage Attributes:

Beta
Cites Data: 37 %
Press Release: 10 %
Event Coverage: 8 %
Government Announcement: 8 %
Legal Policy Regulation: 8 %

Themes Covered:

Not enough data icon

Not enough data

Most Recent Topics:

  • Climate Policy
  • Global Warming
  • Current Affairs
  • International Affairs

Pitching Insights

Lisa M Jarvis’s reporting largely revolves around healthcare and pharmaceuticals, with a strong emphasis on data-driven insights. She frequently cites data in her articles, indicating an interest in evidence-based approaches.

Given the breadth of topics covered within healthcare and pharmaceuticals, Lisa may be open to pitches from experts who can provide compelling data-driven analysis or perspectives on current trends related to youth mental health, infant health, alcohol consumption, obesity management, abortion access issues,sickle cell disease treatment,and pandemic-related stress.

As she does not have a specific geographic focus mentioned and has covered diverse healthcare topics like maternal health and drug pricing alongside other themes such as flu vaccines,cancer treatments,and cholesterol; sources should ensure their expertise aligns with the specific topic being pitched rather than focusing solely on location-specific insights.

This information evolves through artificial intelligence and human feedback. Improve this profile .

Journalists With Similar Coverage:

Based on similarity of content.
Publications
Most recent topics
Not enough data
Publications
Most recent topics
Not enough data
Publications
Most recent topics
Not enough data
Publications
Most recent topics
Not enough data